The Valley Desk

NCT01732107 · Interventional trial

Dovitinib in BCG Refractory Urothelial Carcinoma With FGFR3 Mutations or Over-expression

Overall registry status Terminated

Phase 2

Conditions Bladder Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov